53515-23-4

Basic information

• Product Name: 3-BROMO-4-OXO-4-P-TOLYL-BUTYRIC ACID
• Synonyms: Benzenebutanoic acid, β-bromo-4-methyl-γ-oxo-
• CAS NO: 53515-23-4
• Molecular Formula: C₁₁H₁₁BrO₃
• Molecular Weight: 271.11
• Mol File: 53515-23-4.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 390.6°Cat760mmHg
• Flash Point: 190°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 8.4E-07mmHg at 25°C
• CAS DataBase Reference: 3-BROMO-4-OXO-4-P-TOLYL-BUTYRIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-4-OXO-4-P-TOLYL-BUTYRIC ACID(53515-23-4)
• EPA Substance Registry System: 3-BROMO-4-OXO-4-P-TOLYL-BUTYRIC ACID(53515-23-4)

Safety Data

• Hazardous Substances Data: 53515-23-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H11BrO3/c1-7-2-4-8(5-3-7)11(15)9(12)6-10(13)14/h2-5,9H,6H2,1H3,(H,13,14)/p-1/t9-/m1/s1

Upstream product

• 4619-20-9 3-(4-methylbenzoyl)propionic acid 

Downstream Products

• 412312-35-7 (2-methyl-4-p-tolyl-thiazol-5-yl)-acetic acid 
• 23821-63-8 (2-phenyl-4-p-tolyl-thiazol-5-yl)-acetic acid 
• 189005-44-5 6-methyl-2-(4-methylphenyl)-imidazo<1,2-a>pyridine-3-acetic acid 
• 116759-28-5 [2-((E)-2-Benzo[1,3]dioxol-5-yl-vinyl)-4-p-tolyl-thiazol-5-yl]-acetic acid 
• 116759-18-3 {2-[(E)-2-(3,4-Dimethoxy-phenyl)-vinyl]-4-p-tolyl-thiazol-5-yl}-acetic acid 
• 116759-03-6 {2-[(E)-2-(2,4-Dichloro-phenyl)-vinyl]-4-p-tolyl-thiazol-5-yl}-acetic acid 
• 116759-08-1 {2-[(E)-2-(3,4-Dichloro-phenyl)-vinyl]-4-p-tolyl-thiazol-5-yl}-acetic acid 
• 116758-84-0 {2-[(E)-2-(2-Fluoro-phenyl)-vinyl]-4-p-tolyl-thiazol-5-yl}-acetic acid 

Relevant articles and documents

INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE

Compounds and salts thereof which are acyl-sulfonamides or certain carboxylic acids and which inhibit microbial growth or attenuate the virulence of pathogenic microorganisms and which inhibit UDP-galactopyranose mutase (UGM). Compounds of the invention include 2-aminothiazoles and triazolothiadiazines, particularly 3,6,7-substituted-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines, and 2-amino and salts thereof. Methods for inhibiting growth or attenuating virulence of microbial pathogens including mycobacterium, for example, M. tuberculosis and M. smegmatis and Klebsiella, for example, Klebsiella pneumoniae. Methods for inhibiting eukaryotic human and animal pathogens, and fungi and nematodes in particular. Methods for treatment of infections by prokaryotic and eukaryotic pathogens employing compounds of the invention.